16-2079425-C-T

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_000548.5(TSC2):​c.3281C>T​(p.Ser1094Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000645 in 1,612,744 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000069 ( 0 hom. )

Consequence

TSC2
NM_000548.5 missense

Scores

1
18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10O:1

Conservation

PhyloP100: 0.116
Variant links:
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012714952).
BP6
Variant 16-2079425-C-T is Benign according to our data. Variant chr16-2079425-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 64856.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2079425-C-T is described in Lovd as [Benign].
BS2
High AC in GnomAdExome4 at 101 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TSC2NM_000548.5 linkuse as main transcriptc.3281C>T p.Ser1094Leu missense_variant 28/42 ENST00000219476.9 NP_000539.2 P49815-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TSC2ENST00000219476.9 linkuse as main transcriptc.3281C>T p.Ser1094Leu missense_variant 28/425 NM_000548.5 ENSP00000219476.3 P49815-1

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152188
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000149
AC:
37
AN:
249142
Hom.:
0
AF XY:
0.000199
AC XY:
27
AN XY:
135384
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00121
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000692
AC:
101
AN:
1460438
Hom.:
0
Cov.:
32
AF XY:
0.000106
AC XY:
77
AN XY:
726504
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00108
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.0000994
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152306
Hom.:
0
Cov.:
33
AF XY:
0.0000403
AC XY:
3
AN XY:
74474
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000621
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000113
ExAC
AF:
0.000198
AC:
24
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Tuberous sclerosis 2 Benign:4
Likely benign, criteria provided, single submitterclinical testingMyriad Genetics, Inc.Aug 06, 2024This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 25, 2024- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabNov 07, 2021- -
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -
Hereditary cancer-predisposing syndrome Benign:2
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsAug 03, 2018This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Benign, criteria provided, single submittercurationSema4, Sema4Sep 16, 2021- -
Tuberous sclerosis syndrome Benign:1Other:1
not provided, no classification providedcurationTuberous sclerosis database (TSC2)-- -
Benign, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthMay 09, 2024- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingQuest Diagnostics Nichols Institute San Juan CapistranoOct 31, 2022The frequency of this variant in the general population (http://gnomad.broadinstitute.org) is higher than would generally be expected for pathogenic variants in this gene. Computational tools predict this amino acid change may be benign. -
Lymphangiomyomatosis;C1846385:Isolated focal cortical dysplasia type II;C1860707:Tuberous sclerosis 2 Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsJan 06, 2022- -
not provided Benign:1
Likely benign, criteria provided, single submitterclinical testingGeneDxJul 25, 2018This variant is associated with the following publications: (PMID: 28481359) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
6.5
DANN
Benign
0.92
DEOGEN2
Benign
0.36
T;.;.;.;.;.;.;.;.;.;.;.;T;.;T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.086
N
LIST_S2
Benign
0.81
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
M_CAP
Benign
0.059
D
MetaRNN
Benign
0.013
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.60
T
MutationAssessor
Benign
0.34
N;.;.;.;.;.;.;.;.;N;.;.;.;.;.
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.53
N;.;.;N;.;N;.;.;N;N;.;.;.;.;N
REVEL
Uncertain
0.32
Sift
Benign
0.28
T;.;.;T;.;T;.;.;T;T;.;.;.;.;T
Sift4G
Benign
0.37
T;.;.;T;.;T;.;.;T;T;.;.;.;.;T
Polyphen
0.0040
B;.;.;.;B;B;.;.;B;B;.;.;.;.;.
Vest4
0.29
MutPred
0.18
Loss of relative solvent accessibility (P = 0.008);.;Loss of relative solvent accessibility (P = 0.008);.;.;.;.;Loss of relative solvent accessibility (P = 0.008);.;Loss of relative solvent accessibility (P = 0.008);.;.;.;.;.;
MVP
0.66
ClinPred
0.014
T
GERP RS
-0.30
Varity_R
0.019
gMVP
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs397514887; hg19: chr16-2129426; COSMIC: COSV54782647; COSMIC: COSV54782647; API